These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31070153)

  • 1. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
    Pandey S; Garg R; Kant S; Verma A; Gaur P
    Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
    Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
    Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
    Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
    Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
    Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Qian W; Huang GZ
    Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.
    Titova E; Christensen A; Henriksen AH; Steinshamn S; Åsberg A
    Chron Respir Dis; 2019; 16():1479972318769762. PubMed ID: 29848051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
    Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B
    J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Wang J; Cao B
    Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
    Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.
    Lin TL; Chen WW; Ding ZR; Wei SC; Huang ML; Li CH
    J Clin Lab Anal; 2019 May; 33(4):e22831. PubMed ID: 30666727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum procalcitonin level and chronic obstructive pulmonary disease.
    Borsi H; Nia EP; Mal-Amir MD; Raji H
    J Family Med Prim Care; 2019 Feb; 8(2):738-740. PubMed ID: 30984705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin, C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation.
    Wang J; Shang H; Yang X; Guo S; Cui Z
    Medicine (Baltimore); 2019 Apr; 98(17):e15171. PubMed ID: 31027061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.